The abstract is read at the publisher; the summary is JClub's.
SCN1B intron 3 retention produces an NMD-sensitive SCN1B -IR transcript that cannot compensate for loss of transmembrane β1, phenocopying Scn1b null mice with seizures and early death.
- Why it matters: DEE52 variants are found in SCN1B -IR, but their functional consequences were unclear. Clarifying whether this retained-intron transcript is expressed and how it affects disease-relevant sodium channel biology is needed.
- What they did: The study tested SCN1B c.449-2A>G in a severe biallelic DEE52 patient, showing SCN1B -IR expression without transmembrane β1 transcripts. It also used a transgenic mouse expressing SCN1B -IR, but not transmembrane β1, and compared phenotypes to Scn1b null mice.
- The result: SCN1B -IR is cell type-specific and NMD-sensitive, and its expression is linked to seizures and early death in mice. These findings suggest SCN1B -IR may be a therapeutic target for NMD-directed strategies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.